Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000993968 | SCV001147225 | uncertain significance | not provided | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002479163 | SCV002790734 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 1A; Autosomal dominant nonsyndromic hearing loss 2B; Erythrokeratodermia variabilis et progressiva 1 | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000993968 | SCV003277533 | uncertain significance | not provided | 2022-09-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 806107). This variant has not been reported in the literature in individuals affected with GJB3-related conditions. This variant is present in population databases (rs748575478, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Lys115Serfs*153) in the GJB3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 156 amino acid(s) of the GJB3 protein. |